Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Clinical Immunology and Immunopathology
|
October 1, 1989
Indomethacin augments lymphokine-activated killer cell generation by patients with malignant mesothelioma
L S Manning, R V Bowman, M R Davis, et al.
Clinical and Experimental Pharmacology & Physiology
|
September 1, 1996
Cyclosporine a immunosuppression in sheep with response enhancement by concomitant ketoconazole
H L O'Donoghue, W J Penhale, L S Manning, et al.
Journal of Interferon Research
|
February 1, 1993
Effect of interferon-alpha 2a on malignant mesothelioma
T I Christmas, L S Manning, M J Garlepp, et al.
British Journal of Cancer
|
December 1, 1992
A model of multiple myeloma: culture of 5T33 murine myeloma cells and evaluation of tumorigenicity in the C57BL/KaLwRij mouse
L S Manning, J D Berger, H L O'Donoghue, et al.
Journal of the National Cancer Institute
|
September 15, 1993
Radiopharmaceutical therapy of 5T33 murine myeloma by sequential treatment with samarium-153 ethylenediaminetetramethylene phosphonate, melphalan, and bone marrow transplantation
J H Turner, P G Claringbold, L S Manning, et al.
International Journal of Cancer
|
January 21, 1991
Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions
L S Manning, D Whitaker, A R Murch, et al.
Cancer Immunology, Immunotherapy : CII
|
December 1, 1994
Patho- and immunobiology of malignant mesothelioma: characterisation of tumour infiltrating leucocytes and cytokine production in a murine model
H Bielefeldt-Ohmann, D R Fitzpatrick, A L Marzo, et al.
Veterinary Immunology and Immunopathology
|
August 11, 2001
Cyclosporin immunosuppression of sheep: pharmacokinetics and allograft survival
A H Rose, K F Ilett, H L O'Donoghue, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Clinical Immunology and Immunopathology
|
October 1, 1989
Indomethacin augments lymphokine-activated killer cell generation by patients with malignant mesothelioma
L S Manning, R V Bowman, M R Davis, et al.
Clinical and Experimental Pharmacology & Physiology
|
September 1, 1996
Cyclosporine a immunosuppression in sheep with response enhancement by concomitant ketoconazole
H L O'Donoghue, W J Penhale, L S Manning, et al.
Journal of Interferon Research
|
February 1, 1993
Effect of interferon-alpha 2a on malignant mesothelioma
T I Christmas, L S Manning, M J Garlepp, et al.
British Journal of Cancer
|
December 1, 1992
A model of multiple myeloma: culture of 5T33 murine myeloma cells and evaluation of tumorigenicity in the C57BL/KaLwRij mouse
L S Manning, J D Berger, H L O'Donoghue, et al.
Journal of the National Cancer Institute
|
September 15, 1993
Radiopharmaceutical therapy of 5T33 murine myeloma by sequential treatment with samarium-153 ethylenediaminetetramethylene phosphonate, melphalan, and bone marrow transplantation
J H Turner, P G Claringbold, L S Manning, et al.
International Journal of Cancer
|
January 21, 1991
Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions
L S Manning, D Whitaker, A R Murch, et al.
Cancer Immunology, Immunotherapy : CII
|
December 1, 1994
Patho- and immunobiology of malignant mesothelioma: characterisation of tumour infiltrating leucocytes and cytokine production in a murine model
H Bielefeldt-Ohmann, D R Fitzpatrick, A L Marzo, et al.
Veterinary Immunology and Immunopathology
|
August 11, 2001
Cyclosporin immunosuppression of sheep: pharmacokinetics and allograft survival
A H Rose, K F Ilett, H L O'Donoghue, et al.
Page
of 3